Understanding treatment patterns and patient-reported outcomes associated with the use of authorized generics and corresponding independent generics across multiple therapeutic areas.
Justine T AlderferJose M J AlvirJoseph P CookKim GilchristMartine C MaculaitisJeffrey ThompsonPublished in: Current medical research and opinion (2022)
PRO differences were often small in magnitude and varied by therapeutic area. The impact of switching should consider observed PRO differences, patient preferences, and market availability of AG and IG alternatives.